Envestnet Asset Management
ETON icon

Envestnet Asset Management’s Eton Pharmaceutcials ETON Stock Holding History

Envestnet Asset Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$347K Sell
9,582
-1,157
-11% -$33.9K ﹤0.01% 4342
2026
Q1 		$265K Sell
10,739
-205
-2% -$3.58K ﹤0.01% 4350
2025
Q4 		$185K Sell
10,944
-433
-4% -$7.62K ﹤0.01% 4288
2025
Q3 		$247K Sell
11,377
-11,673
-51% -$194K ﹤0.01% 4195
2025
Q2 		$328K Buy
23,050
+5,734
+33% +$90.6K ﹤0.01% 3968
2025
Q1 		$225K Sell
17,316
-424
-2% -$6.41K ﹤0.01% 4087
2024
Q4 		$236K Buy
+17,740
New +$180K ﹤0.01% 4012

Other funds holding ETON

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
LK
Lumbard & Kellner Hollis, New Hampshire $330M AUM 65.94% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
ACA
Anchor Capital Advisors Boston, Massachusetts $3.56B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management's ETON Position: Q2 2026 in Review

Envestnet Asset Management reduced its Eton Pharmaceutcials (ETON) stake by 11% in Q2 2026, selling an estimated $33.9K and leaving 9,582 shares worth $347K. The position accounts for ﹤0.01% of the portfolio, ranked #4342.

Envestnet Asset Management first reported a position in ETON in Q4 2024 and has held it in 7 quarters since. 59 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Envestnet Asset Management held 9,582 shares of Eton Pharmaceutcials worth $347K as of Q2 2026.
  • Envestnet Asset Management sold 1,157 Eton Pharmaceutcials shares in Q2 2026, an estimated $33.9K.
  • Eton Pharmaceutcials made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #4342 holding.
  • Envestnet Asset Management first reported a position in Eton Pharmaceutcials in Q4 2024 and has held it in 7 quarters since.
  • 59 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.